Why Some Biotech Companies Are Turning to SPACs

Why Some Biotech Companies Are Turning to SPACs

Source: 
Motley Fool
snippet: 

A special purpose acquisition company (SPAC) is a shell company that raises money through an initial public offering (IPO) in order to take a company public through acquisition. Companies that want to go public usually go the route of an IPO; however, SPACs have risen in popularity recently due to their ability to get to market faster and surging demand from investors.